There is light at the end of the infection control tunnel – particularly when it comes to the growing incidences of methicillin-resistant Staphylococcus aureus (MRSA) infections – with the FDA's clearance this week of Cepheid's (Sunnyvale, California) GeneXpert MRSA/SA Skin and Soft Tissue Infection (SSTI) test, which can provide clinicians with results in less than a hour, compared to traditional cultured tests which can take days. (Medical Device Daily)